Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

100.30 +1.29 (+1.30%)
Official Closing Price Updated: 7:00 PM EST, Dec 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026 ↗
They could grow into their valuation over the next few years. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Great Rotation: Tech Exodus Fuels Dow's Record Run While Nasdaq Struggles
As of December 12, 2025, the financial markets are witnessing a significant "Great Rotation," a pronounced shift of capital from high-growth technology and Artificial Intelligence (AI) stocks to more... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
The Green Revolution in Silicon: Semiconductor Manufacturing Embraces Sustainability
The semiconductor industry, the foundational bedrock of our digital world and the engine powering the explosive growth of artificial intelligence, is undergoing a profound transformation. Driven by... 
Via TokenRing AI
Topics Artificial Intelligence Climate Change Economy
News headline image
Merck Receives Positive EU CHMP Opinion for Expanded Use of WINREVAIR™ (sotatercept) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension)
From Merck & Co., Inc.
Via Business Wire
News headline image
2 Mega-Cap Stocks with Exciting Potential and 1 We Ignore
Megacap stocks are behemoths that set the tone for their industries, and their massive scale typically leads to wide moats. However, the downside is that most have already exploited their existing... 
Via StockStory
News headline image
Dividend Stocks for 2026: Where to Invest as the Market Cools ↗
Via MarketBeat
News headline image
2 Pharmaceutical Stocks to Buy at a Discount ↗
Investors are currently so focused on one type of drug that even good companies are being left on the sidelines. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Healthcare Sector Falters: S&P 500's Biggest Loser Amid Broader Market Caution
New York, NY – December 9, 2025 – The S&P 500 Healthcare sector found itself in a precarious position today, emerging as the biggest underperformer among its peers. While the broader S&P 500 index... 
Via MarketMinute
Topics ETFs Economy Intellectual Property
News headline image
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Tuesday as we examine the latest happenings in today's session. 
Via Chartmill
News headline image
Here's 1 Major Catalyst Behind Merck Stock's Recent 3.8% Bump ↗
The company is finding ways to overcome the headwinds it will encounter in the medium term. 
Via The Motley Fool
News headline image
1 Major Factor Behind the Healthcare Sector's Recent Surge ↗
Blockbuster drugs are a major driver of the growth of healthcare stocks. 
Via The Motley Fool
News headline image
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? ↗
With yields between 3.4% and 6.8%, you'll need to think carefully about the highest yields in the Dow before you buy them. 
Via The Motley Fool
Topics Economy Stocks
News headline image
Merck's Stock is Suddenly Soaring, but Is the Struggling Healthcare Giant a Buy? ↗
After a long hiatus, why are the bulls so willing to buy in now? 
Via The Motley Fool
Topics Intellectual Property
News headline image
Do These 3 Healthcare Stocks Need a Checkup? ↗
These three drugmakers are all well off their recent highs. Is this a sign of opportunity or risk? 
Via The Motley Fool
Topics Intellectual Property
News headline image
Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now? ↗
The healthcare stock could skyrocket if ivonescimab obtains approval from regulators, but there's still plenty of risk here. 
Via The Motley Fool
News headline image
Is This Pharmaceutical Giant a Buy After a Major Acquisition? ↗
The rebound is well underway. 
Via The Motley Fool
Topics Death
News headline image
These Are the 3 Hottest Stocks in the S&P 500 Heading Into the New Year. Should You Invest in Them? ↗
After tepid performances throughout most of 2025, these stocks are showing some upward momentum. 
Via The Motley Fool
Topics Stocks
News headline image
With Netflix's 10-for-1 Stock Split Complete, Here Are 3 Growth Stocks to Buy in December That Could Issue Stock Splits in 2026 ↗
Surging stock prices and earnings growth potential make Meta Platforms, ASML, and Eli Lilly ripe for stock splits in the new year. 
Via The Motley Fool
Topics Artificial Intelligence Economy Stocks
News headline image
FDA Conditionally Approves Merck Animal Health's EXZOLT™ CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis)
From Merck & Co., Inc.
Via Business Wire
News headline image
3 Top ETFs I Plan to Pile Into in December to Boost My Passive Income in 2026 ↗
These ETFs can provide me with lots of passive income. 
Via The Motley Fool
Topics ETFs Stocks
News headline image
Global Prescription Drug Market Poised for Trillion-Dollar Surge by 2035
The global prescription drugs market is on the cusp of a significant expansion, with recent market reviews and forecasts projecting a robust growth trajectory through 2035. This anticipated surge,... 
Via MarketMinute
Topics Artificial Intelligence Death Intellectual Property
News headline image
Wall Street's Tentative Triumph: Dow, S&P 500, Nasdaq Edge Higher Amidst Shifting Tides
Wall Street has recently concluded a tumultuous yet ultimately resilient period, with the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite all managing to edge higher in late November and... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
Via Investor Brand Network
Topics Government
News headline image
Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
From BioMedWire
Via GlobeNewswire
News headline image
2 Monster Stocks in the Making to Buy and Hold ↗
There's still time to get in on these rising stars. 
Via The Motley Fool
News headline image
1 Value Stock to Target This Week and 2 We Question
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued... 
Via StockStory
News headline image
Global Markets Brace as Treasury Yields Surge Amidst BOJ Speculation and Risk Aversion
As December 1, 2025, dawns, global financial markets are grappling with a significant uptick in Treasury yields, a movement primarily catalyzed by a substantial sell-off in Japanese government debt and... 
Via MarketMinute
Topics Bonds Economy Stocks
News headline image
Treasury Yields Surge Amid Global Shifts and Fiscal Concerns: A Deep Dive into Market Implications
New York, NY – December 1, 2025 – U.S. Treasury yields have experienced a significant climb today, marking a pivotal moment for financial markets. This ascent, driven by a complex interplay of global... 
Via MarketMinute
Topics Bonds Credit Cards Economy
News headline image
Merck Showcases Data for Alzheimer's Disease Candidates MK-2214 and MK-1167 at CTAD 2025
From Merck Sharp & Dohme
Via Business Wire
News headline image
These Underrated Companies Could Be "Training-Wheels" Stocks for Long-Term Wealth Builders ↗
If you are thinking in decades and not days, this trio of dividend stocks could be the perfect starting point for your fledgling portfolio. 
Via The Motley Fool
Topics Energy Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.